The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits
Open accessAbstract
The Onduo Virtual Diabetes Clinic (VDC) telehealth technology/care model for adults with type 2 diabetes (T2D) combines connected devices, remote lifestyle coaching, and clinical support with a mobile App. Key differentiating program features are the availability of live video consultations with board-certified endocrinologists for medication management and real-time continuous glucose monitor use for higher-risk participants. Preliminary data ( n = 740) suggest that participation was associated with a significant improvement in HbA1c with up to 6 months follow-up in those not meeting treatment targets. HbA1c decreased by 2.3% ± 1.9%, 0.7% ± 1.0%, and 0.2% ± 0.8% across baseline categories of >9.0%, 8.0%-9.0% and 7.0% to <8.0%, respectively (all P < .001). These findings suggest that the VDC has potential to support individuals with T2D and their clinicians in diabetes management between office visits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Virta health, Accolade and Onduo by Verily (Alphabet) have all developed applications that aim to improve diabetes control, with some demonstrating improvement in hemoglobin A1c levels in individuals who followed the programs 75 .”
From Multimodal biomedical AI (2022) · cites this paper as [75]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Others assist in improving diabetes outcomes by remotely monitoring clinical data (for instance, wireless monitoring of glucose levels, weight, or blood pressure) and providing feedback and coaching (266-271).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [269]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Diabetes 2030: Insights from Yesterday, Today, and Future Trends
Rowley, W. R., Bezold, C., Arikan, Y., Byrne, E., & Krohe, S. (2017) · Population Health Management · doi:10.1089/pop.2015.0181 · Cited by 655
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Prevalence of diagnosed diabetes in adults by diabetes type – United States, 2016
Bullard, K. M., Cowie, C. C., Lessem, S. E., Saydah, S. H., Menke, A., Geiss, L. S., Orchard, T. J., Rolka, D. B., & Imperatore, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a2 · Cited by 512
Hou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411
Introduction: Standards of Medical Care in Diabetes—2019
(2019) · Diabetes Care · doi:10.2337/dc19-sint01 · Cited by 356
Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2012) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 301
2017 National Standards for Diabetes Self-Management Education and Support
Beck, J., Greenwood, D. A., Blanton, L., Bollinger, S. T., Butcher, M. K., Condon, J. E., Cypress, M., Faulkner, P., Fischl, A. H., Francis, T., et al. (2018) · The Diabetes Educator · doi:10.1177/0145721718754797 · Cited by 288
Tomky, D., Tomky, D., Cypress, M., Dang, D., Maryniuk, M., Peyrot, M., & Mensing, C. (2008) · The Diabetes Educator · doi:10.1177/0145721708316625 · Cited by 270
Research works printed but not linked: 2
- Centers for Disease Control and Prevention, 2019, 2017 National Diabetes Statistics Report
- Bollyky JB, 2018, J Diabetes Res, 3961730
Cited by
Foundation models for generalist medical artificial intelligence
Moor, M., Banerjee, O., Abad, Z. S. H., Krumholz, H. M., Leskovec, J., Topol, E. J., & Rajpurkar, P. (2023) · Nature · doi:10.1038/s41586-023-05881-4 · Cited by 2,028
Acosta, J. N., Falcone, G. J., Rajpurkar, P., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-022-01981-2 · Cited by 1,365
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
A deep learning system for predicting time to progression of diabetic retinopathy
Dai, L., Sheng, B., Chen, T., Wu, Q., Liu, R., Cai, C., Wu, L., Yang, D., Hamzah, H., Liu, Y., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02702-z · Cited by 339
Metadata
- Authors
- Dixon, R. F., Zisser, H., Layne, J. E., Barleen, N. A., Miller, D. P., Moloney, D. P., Majithia, A. R., Gabbay, R. A., & Riff, J.
- Affiliations
- Onduo LLC, Newton, MA, USA
- Verily Life Sciences LLC (United States) (US)
- University of California San Diego (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Layne, Jennifer E.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2019-11-25
- Volume
- 14
- Issue
- 5
- Pages
- 908-911
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC7477772
- OpenAlex
- W2991558875
- Cited by
- 80
- References
- 18
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 13 · 2023: 12 · 2022: 13 · 2021: 18 · 2020: 13
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Diabetes Science and Technology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Onduo, LLC
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, telemedicine, continuous glucose monitoring, HbA1c, glycemic control, mobile application, medication management, video consultation, IoT devices
- MeSH terms
- Glycemic Control, Ambulatory Care Facilities, Blood Glucose, Diabetes Mellitus, Type 2, Endocrinology, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Predictive Value of Tests, Time Factors, United States, Blood Glucose Self-Monitoring, Biomarkers, Treatment Outcome, Telemedicine, Monitoring, Ambulatory, Risk Reduction Behavior, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits. https://app.cochat.ai/papers/10.1177/1932296819888662
- The paper
- Dixon, R. F., Zisser, H., Layne, J. E., Barleen, N. A., Miller, D. P., Moloney, D. P., Majithia, A. R., Gabbay, R. A., & Riff, J. (2020). A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296819888662
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.